InfuSystem Holdings (INFU) FCF Margin (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly FCF Margin came in at 2.41% in Q1 2026, down 481.0% YoY from 0.63% in Q1 2025, and down 80.39% on a QoQ basis from 12.31% in Q4 2025.
InfuSystem Holdings (INFU) FCF Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of FCF Margin data on file, last reported at 2.41% in Q1 2026.
- Quarterly FCF Margin fell 481.0% year-over-year to 2.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.78% (down 379.0% YoY) and the FY2025 annual result came in at 14.86%, down 176.0% from the prior year.
- FCF Margin fell to 2.41% in Q1 2026, from 12.31% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 32.55% in Q3 2024 to a low of 1.54% in Q1 2023.
- A 5-year average of 12.82% and a median of 11.22% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin sank 1663 bps — and 2024, when it soared 2486 bps.
- Tracing INFU's FCF Margin over 5 years: stood at 11.22% in 2022, then jumped by 88 bps to 21.13% in 2023, then climbed by 22 bps to 25.84% in 2024, then tumbled by 52 bps to 12.31% in 2025, then slumped by 80 bps to 2.41% in 2026.
- The last three FCF Margin figures came in at 2.41% (Q1 2026), 12.31% (Q4 2025), and 23.06% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.73% |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 18.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.55% |
| Mar 31, 2026 | 2.41% |
| Dec 31, 2025 | 12.31% |
| Sep 30, 2025 | 23.06% |
| Jun 30, 2025 | 16.48% |
| Mar 31, 2025 | 7.23% |
| Dec 31, 2024 | 25.84% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | 4.20% |
| Mar 31, 2024 | 2.35% |
| Dec 31, 2023 | 21.13% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 7.17% |
| Mar 31, 2023 | -1.54% |
| Dec 31, 2022 | 11.22% |
| Sep 30, 2022 | 10.65% |
| Jun 30, 2022 | 20.11% |
| Mar 31, 2022 | 15.08% |
| Dec 31, 2021 | 10.68% |
| Sep 30, 2021 | 22.67% |